Pangea Pharma Launches Sdamlo, First FDA-Approved Amlodipine
15 Apr 2026 //
PHARMIWEB
Pangea Lab Partners with Gene Solutions on U.S. AI Cancer Tests
28 Jan 2026 //
INDPHARMAPOST
Pangea’s Receives First Generic Approval for Buspirone HCl in US
13 Mar 2025 //
FDA

Market Place
Sourcing Support